Health  Vol.4 No.10 A , October 2012
Retrospective survey of avian influenza H5N1 infection in Northern Vietnam by using a combinational serologic assay
ABSTRACT
Outbreaks of highly pathogenic avian influenza H5N1 virus have occurred in Vietnam since 2003. However, how people got avian H5N1 infection in Northern Vietnam is still unclear. We therefore performed a combination of the serologic assays H5N1 ELISA and H5 western blot to detect anti-H5N1 specific antibodies. Sera samples of 149 subjects with suspected H5N1 infection from three provinces of Northern Vietnam were collected from September 2006 to March 2007. Our results indicated that this combinational assay showed high sensitivity (100%) and specificity (95%) when compared with hemagglutinin inhibition (HI) assay. Fifty-one sera samples (34.2%) contained specific antibodies against H5N1 viruses. Poultry raisers (32/77; 41.6%) showed higher H5N1 infection rates than slaughterers (12/41; 29.3%) and health care workers (7/31; 22.6%). Contact history with sick or dead poultry in household or slaughter-house (p < 0.05) and lack of protective equipment use when in contact with dead poultry (p < 0.05) were risk factors found to be associated with H5N1 infection. In this study, we established an alternative serologic assay for H5N1 diagnosis, and we hereby present seroepidemiologic data of H5N1 infection in Northern Vietnam.

Cite this paper
Luong, H. , Wang, S. , Trao, V. , Chen, M. , Huang, J. , Cam, P. , Lin, Y. and Chen, Y. (2012) Retrospective survey of avian influenza H5N1 infection in Northern Vietnam by using a combinational serologic assay. Health, 4, 974-982. doi: 10.4236/health.2012.430149.
References
[1]   Pawitan, J.A. (2007) Human H5N1 influenza. The New England Journal of Medicine, 356, 1376-1377. Hdoi:10.1056/NEJMc063637

[2]   Dinh, P.N., Tien, N.T., Hien, N.T., Mai Le, T.Q., Phong Le, H., Tuan Le, V., Van Tan, H., Nguyen, N.B., Van Tu, P. and Phuong, N.T. (2006) Risk factors for human infection with avian influenza A H5N1, Vietnam, 2004. Emerging Infectious Diseases Journal, 12, 1841-1847. Hdoi:10.3201/eid1212.060829

[3]   Subbarao, K., Klimov, A., Katz, J., Regnery, H., Lim, W., Hall, H., Perdue, M., Swayne, D., Bender, C., Huang, J., et al. (1998) Characterization of an avian influenza A (H5N1) virus isolated from a child with a fatal respiratory illness. Science, 279, 393-396. Hdoi:10.1126/science.279.5349.393

[4]   Wang, T.T., Parides, M.K. and Palese, P. (2012) Seroevidence for H5N1 influenza infections in humans: Metaanalysis. Science, 335, 1463. Hdoi:10.1126/science.1218888

[5]   Renegar, K.B. (1992) Influenza virus infections and immunity: A review of human and animal models. Laboratory Animal Science, 42, 222-232.

[6]   Silverstein, G. (2006) Preparing for pandemic influenza. Lancet, 367, 1239-1240. Hdoi:10.1016/S0140-6736(06)68537-1

[7]   Pontoriero, A.V., Baumeister, E.G., Campos, A.M., Savy, V.L., Lin, Y.P. and Hay, A. (2003) Antigenic and genomic relation between human influenza viruses that circulated in Argentina in the period 1995-1999 and the corresponding vaccine components. Journal of Clinical Virology, 28, 130-140. Hdoi:10.1016/S1386-6532(02)00274-3

[8]   Carrat, F. and Flahault, A. (2007) Influenza vaccine: The challenge of antigenic drift. Vaccine, 25, 6852-6862. Hdoi:10.1016/j.vaccine.2007.07.027

[9]   Gagneux, P., Cheriyan, M., Hurtado-Ziola, N., van der Linden, E.C., Anderson, D., McClure, H., Varki, A. and Varki, N.M. (2003) Human-specific regulation of alpha 2-6-linked sialic acids. The Journal of Biological Chemistry, 278, 48245-48250. Hdoi:10.1074/jbc.M309813200

[10]   Lavanchy, D. (1998) The WHO update on influenza A (H5N1) in Hong Kong. Euro Surveillance, 3, 23-25.

[11]   Ligon, B.L. (2005) Avian influenza virus H5N1: A review of its history and information regarding its potential to cause the next pandemic. Seminars in Pediatric Infectious Diseases, 16, 326-335. Hdoi:10.1053/j.spid.2005.07.002

[12]   Abdel-Ghafar, A.N., Chotpitayasunondh, T., Gao, Z., Hayden, F.G., Nguyen, D.H., de Jong, M.D., Naghdaliyev, A., Peiris, J.S., Shindo, N., Soeroso, S., et al. (2008) Update on avian influenza A (H5N1) virus infection in humans. The New England Journal of Medicine, 358, 261-273. Hdoi:10.1056/NEJMra0707279

[13]   Dung Nguyen, T., Vinh Nguyen, T., Vijaykrishna, D., Webster, R.G., Guan, Y., Malik Peiris, J.S. and Smith, G.J, (2008) Multiple sublineages of influenza A virus (H5N1), Vietnam, 2005-2007. Emerging Infectious Diseases Journal, 14, 632-636. Hdoi:10.3201/eid1404.071343

[14]   Le, M.T., Wertheim, H.F., Nguyen, H.D., Taylor, W., Hoang, P.V., Vuong, C.D., Nguyen, H.L., Nguyen, H.H., Nguyen, T.Q., Nguyen, T.V., et al. (2008) Influenza A H5N1 clade 2.3.4 virus with a different antiviral susceptibility profile replaced clade 1 virus in humans in northern Vietnam. PLoS One, 3, e3339. Hdoi:10.1371/journal.pone.0003339

[15]   Beigel, J.H., Farrar, J., Han, A.M., Hayden, F.G., Hyer, R., de Jong, M.D., Lochindarat, S., Nguyen, T.K., Nguyen, T.H., Tran, T.H., et al. (2005) Avian influenza A (H5N1) infection in humans. The New England Journal of Medicine, 353, 1374-1385. Hdoi:10.1056/NEJMra052211

[16]   Imai, M., Ninomiya, A., Minekawa, H., Notomi, T., Ishizaki, T., Van Tu, P., Tien, N.T., Tashiro, M. and Odagiri, T. (2007) Rapid diagnosis of H5N1 avian influenza virus infection by newly developed influenza H5 hemagglutinin gene-specific loop-mediated isothermal amplification method. Journal of Virological Methods, 141, 173-180. Hdoi:10.1016/j.jviromet.2006.12.004

[17]   Wang, S., et al. (2009) Generating and characterizing monoclonal and polyclonal antibodies against avian H5N1 hemagglutinin protein. Biochemical and Biophysical Research Communications, 382, 691-696. Hdoi:10.1016/j.bbrc.2009.03.119

[18]   Rowe, T., et al. (1999) Detection of antibody to avian influenza A (H5N1) virus in human serum by using a combination of serologic assays. Journal of Clinical Microbiology, 37, 937-943.

[19]   Wang, S., et al. (2009) Generating and characterizing monoclonal and polyclonal antibodies against avian H5N1 hemagglutinin protein. Biochemical and Biophysical Research Communications, 382, 691-696. Hdoi:10.1016/j.bbrc.2009.03.119

[20]   Grund, S., et al. (2010) Comparison of hemagglutination inhibition assay, an ELISA-based micro-neutralization assay and colorimetric microneutralization assay to detect antibody responses to vaccination against influenza A H1N1 2009 virus. Journal of Virological Methods, 171, 369-373. Hdoi:10.1016/j.jviromet.2010.11.024

[21]   Kayali, G., et al. (2008) Testing human sera for antibodies against avian influenza viruses: Horse RBC hemagglutination inhibition vs. microneutralization assays. Journal of Clinical Virology, 43, 73-78. Hdoi:10.1016/j.jcv.2008.04.013

[22]   (1997) Isolation of avian influenza A (H5N1) viruses from humans—Hong Kong, May-December 1997. Morbidity and Mortality Weekly Report, 46, 1204-1207.

[23]   Hinshaw, V.S., et al. (1981) Replication of avian influenza A viruses in mammals. Infection and Immunity, 34, 354-361.

[24]   Rowe, T., et al. (1999) Detection of antibody to avian influenza A (H5N1) virus in human serum by using a combination of serologic assays. Journal of Clinical Microbiology, 37, 937.

[25]   Bridges, C.B., et al. (2002) Risk of influenza A (H5N1) infection among poultry workers, Hong Kong, 1997-1998. The Journal of Infectious Diseases, 185, 1005-1010. Hdoi:10.1086/340044

[26]   Katz, J.M., et al. (1999) Antibody response in individuals infected with avian influenza A (H5N1) viruses and detection of anti-H5 antibody among household and social contacts. The Journal of Infectious Diseases, 180, 1763-1770. Hdoi:10.1086/315137

[27]   WHO (2005) Recommended laboratory test to identify avian influenza A virus in specimens from humans. World Health Organization, June-September Technical Working Group, Geneva. Hhttp://www.cdc.gov.tw/downloadfile.aspx?fid=FCE2E4E34EB2CCE3

[28]   Schultsz, C., et al. (2005) Avian influenza H5N1 and healthcare workers. Emerging Infectious Diseases Journal, 11, 1158-1159. Hdoi:10.3201/eid1107.050070

[29]   Beigel, J., et al. (2005) Avian influenza A (H5N1) infection in humans. The New England Journal of Medicine, 353, 1374. Hdoi:10.1056/NEJMra052211

[30]   Sultana, R., et al. (2012) Bangladeshi backyard poultry raisers’ perceptions and practices related to zoonotic transmission of avian influenza. Journal of Infection in Developing Countries, 6, 156-165.

[31]   Lukrafka, J.L., et al. (2007) Determining risk factors for infection with influenza A (H5N1). Emerging Infectious Diseases Journal, 13, 955-956. Hdoi:10.3201/eid1306.070025

[32]   Buxton Bridges, C.K.J., et al. (2000) Risk of influenza A (H5N1) infection among health care workers exposed to patients with influenza A (H5N1), Hong Kong. The Journal of Infectious Diseases, 181, 334-348.

[33]   Dinh, P.N., et al. (2006) Risk factors for human infection with avian influenza A H5N1, Vietnam, 2004. Emerging Infectious Diseases Journal, 12, 1841-1847. Hdoi:10.3201/eid1212.060829

[34]   Areechokchai, D., et al. (2006) Investigation of avian influenza (H5N1) outbreak in humans—Thailand, 2004. Morbidity and Mortality Weekly Report, 55, 3-6.

[35]   Mounts, A.W., et al. (1999) Case-control study of risk factors for avian influenza A (H5N1) disease, Hong Kong, 1997. The Journal of Infectious Diseases, 180, 505-508. Hdoi:10.1086/314903

[36]   Vong, S., Coghlan, B., Mardy, S., Holl, D., Seng, H., Ly, S., Miller, M., Buchy, P., Froehlich, Y. and Dufourcq, J. (2006) Low frequency of poultry-to-human H5N1 virus transmission, southern Cambodia, 2005. Emerging Infectious Diseases Journa, 12, 6-424.

[37]   Ortiz, J., et al. (2007) Lack of evidence of avian to human transmission of avian influenza A (H5N1) virus among poultry workers, Kano, Nigeria, 2006. The Journal of Infectious Diseases, 196, 1685-1691. Hdoi:10.1086/522158

[38]   Apisarnthanarak, A., et al. (2005) Seroprevalence of anti-H5 antibody among Thai health care workers after exposure to avian influenza (H5N1) in a tertiary care center. Clinical Infectious Diseases, 40, e16-e18. Hdoi:10.1086/427034

 
 
Top